Yes, a $2M Licensing payment (hypothetical but knew you would take issue) is no big deal compared to the "Millions" in kits that were previously touted, and "expected" as they were in Negotiations with Large Pharma companies for them, remember? Now we have nothing to go by as far as Revs. Remember, we were supposed to have ABBIE kits Revs AND, AND Licensing?
This clown knows full well the quote you provided, and it backs up that anything they get in short term Licensing needs to be paid to Aguilar...so as I said...unless it's a large Licensing agreement, it won't affect the bottom line of SHMN for some time...which means we barely have a justifiable MC at .0007 as it is.
Did you forget, I was pumping gummies, and RX, because it was about cash flow and limiting the need for dilution.
This management Team/Hires was supposed to be better than most OTC's. Turns out they did the same as all of them, and disrespected shareholders by grinding the stock into the pavement. 5 year lows.
Has Aguilar been paid his initial $3 Million CASH? Nope.
I know it's hard for you myth, but maybe you could resist the name calling and insults...
Market Data 
Markets 
AI
